[Exposed] The Alzheimer’s Con That Fooled America

It was a sleight of hand trick that would have made Houdini blush…

But now the secret has been revealed… and it should leave every American senior furious.

When the first anti-plaque Alzheimer’s drugs hit the market about five years ago, they were supposed to transform how we treat this truly terrible disease.

The premise was simple. Attack the amyloid plaques linked to Alzheimer’s, and you could halt – or even reverse – memory loss.

But then patients, caregivers, and doctors started noticing something alarming…

The drugs didn’t work – at least not in any significant way.

A massive review by the Cochrane Collaboration even concluded that they had “no clinically meaningful effect.”

But how could that be?

How could drugs that allegedly performed so well in clinical trials be failing so spectacularly in the real world?

Well, now we know…

Drug companies are being accused of using data manipulation on a MASSIVE scale to make these medications appear DOZENS of times more effective than they are.

They peddled false hope and snake oil to countless Alzheimer’s patients and their families… all to make a buck.

And it’s time for these folks to be held accountable.

A recent analysis from Brown University found that Big Pharma is using a statistical magic trick known as “quantile aggregation” to overstate the benefits of its Alzheimer’s drugs.

It’s a pretty convenient way to manipulate numbers when a drug isn’t performing very well.

Now, it can get pretty complicated… but I’ll give you a simple example of how it can work.

Imagine a clinical trial where, instead of testing a drug, the two groups were running a race.

The first group finished the race, on average, in 10 minutes. The second group finished in 9 minutes and 58 seconds.

So, there’s basically no difference at all… until you decide to group the results by who finished in under 10 minutes, and who didn’t.

Suddenly, it starts to look like there are real differences among the groups… even though there aren’t.

Well, that’s basically what they did with these Alzheimer’s drugs to hide the fact that people weren’t significantly improving.

And Brown researchers found that this statistical nonsense makes the drugs appear 29 times more effective than they are.

That’s why they’re not working, friend. Because they never really worked.

And Big Pharma is laughing all the way to the bank, pocketing hundreds of millions of dollars per year. Some of these drugs are selling for around $30,000 a year.

That isn’t just snake oil. That’s Gucci snake oil.

What galls me is that, if Brown researchers could figure this out, how the heck did no one else see it?

Either government regulators didn’t understand – or didn’t care. And I suspect the latter.

It’s time to hold these drug companies accountable, stop the gravy train, and get these meds off the market.

These treatments are making drug companies a fortune, while taking advantage of truly desperate people.

It’s heartbreaking. It’s wrong. And whether we allow it to continue will say a lot about us as a people.

In Your Corner,

Dr. Allan Spreen

In Case You Missed It

• The “Hangover Cure” That Wipes Out 90% of Cancer Cells
• This Common Arthritis Drug Boosts Shingles Risk 137%
• [Buried] Rare Fruit REVERSES Parkinson’s Damage
• Is This Daily Habit Giving You Alzheimer’s?!
• [Breakthrough] Weird Apple Compound CRUSHES Pancreatic Tumors?!
• [Exposed] Who’s REALLY Driving the Painkiller Epidemic? (And How to Stay Safe)
• [Discovered] “Bee Glue” Wipes Out Cancer in Just Hours

Sources:

• Flanders MD, Caunca M, La Joie R, Schneider LS, Ackley SF. Methodological Considerations for Quantile Aggregation in Alzheimer Disease Trials. JAMA Neurol. Published online May 18, 2026. doi:10.1001/jamaneurol.2026.1240
• George, G. (2026). Study Questions Methods Used in Alzheimer’s Drug Analysis. MedPageToday. https://www.medpagetoday.com/neurology/alzheimersdisease/121382